4,6-diamino-5-n-formamidopyrimidine has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berumen, J; Carvajal, M; Guardado-Estrada, M | 1 |
| Foksinski, M; Jaruga, P; Makarewicz, R; Olinski, R | 1 |
2 other study(ies) available for 4,6-diamino-5-n-formamidopyrimidine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
The presence of aflatoxin B₁-FAPY adduct and human papilloma virus in cervical smears from cancer patients in Mexico.
Topics: Adult; Aflatoxin B1; Aged; Biomarkers, Tumor; Case-Control Studies; Chromatography, High Pressure Liquid; DNA Adducts; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Human papillomavirus 16; Human papillomavirus 18; Humans; Mexico; Middle Aged; Pyrimidines; Reproducibility of Results; Uterine Cervical Neoplasms | 2012 |
Oxidative DNA base damage in cancerous tissues of patients undergoing brachytherapy.
Topics: Adenine; Brachytherapy; Cytosine; DNA Damage; DNA, Neoplasm; Female; Gas Chromatography-Mass Spectrometry; Guanine; Humans; Oxidation-Reduction; Pyrimidines; Uracil; Uterine Cervical Neoplasms | 1998 |